Study of AC-201 in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.
Also called NCT01276106
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 259 participants
- Sponsor
- TWi Biotechnology, Inc.
- Registry
-
NCT01276106
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01276106. Randomized; triple masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2014-11-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of AC-201 in Patients With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- AC-201, 25mg
- Intervention (Drug)
- AC-201, 50mg
- Intervention (Drug)
- AC-201, 75mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- TWi Biotechnology, Inc.
Record details
- Record id
cardio:ct-nct01276106- Content hash
5578edf2f80ed13dfa4cad559c4ce279d87ad8f03353f0f5381ea471f01d4f8d